Document is current
Any future updates will be listed below
-
Authors
Brandes, Ralf P. http://orcid.org/0000-0002-8035-0048
Dueck, Anne
Engelhardt, Stefan
Kaulich, Manuel
Kupatt, Christian
De Angelis, Maria Teresa
Leisegang, Matthias S.
le Noble, Ferdinand
Moretti, Alessandra
Müller, Oliver J.
Skryabin, Boris V.
Thum, Thomas
Wurst, Wolfgang
-
Funding
Funding for this research was provided by:
Deutsches Zentrum für Herz-Kreislaufforschung
Deutsche Gesellschaft für Kardiologie-Herz und Kreislaufforschung.
Projekt DEAL
- License Information
-
More Information
Article History
Received: 17 September 2020
Accepted: 9 December 2020
First Online: 15 January 2021
Compliance with ethical standards
:
: The following conflict of interest do exist: Thomas Thum is founder and shareholder of Cardior Pharmaceuticals GmbH. Manuel Kaulich is co-founder, shareholder, and chief scientific officer of Vivlion GmbH. The following authors declare not to have a conflict of interest: Ralf P. Brandes, Anne Dueck, Stfan Engelhardt, Christian Kupatt, Maria Terese De Angelis, Matthias S. Leisegang, Ferdinand le Noble, Alessandra Moretti, Oliver J. Müller, Boris V. Skryabin, and Wolfgang Wurst.
: Does not apply.
: All authors have actively participated in this work and give their consent.
: All authors have read the final version of the manuscript and consent to its publication.
